Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Otolaryngol Pol ; 67(3): 113-34, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23719268

RESUMO

The role of human papilloma viruses (HPV) in malignant and nonmalignant ENT diseases and the corresponding epidemiological burden has been widely described. International head and neck oncology community discussed growing evidence that oral HPV infection contributes to the risk of oro-pharyngeal carcinoma (OPC) and recommended HPV testing as a part of the work up for patients with OPC. Polish Society of ENT Head Neck Surgery and National Chamber of Laboratory Diagnosticians have worked together to define the minimum requirements for assigning a diagnosis of HPV-related conditions and testing strategy that include HPV specific tests in our country. This paper briefly frames the literature information concerning low risk (LR) and high risk (HR) HPV, reviews the epidemiology, general guidance on the most appropriate biomarkers for clinical assessment of HPV. The definition of HPV-related cancer was presented. The article is aiming to highlight some of major issues for the clinician dealing with patients with HPV-related morbidities and to introduce the diagnostic algorithm in Poland.


Assuntos
Neoplasias Laríngeas/diagnóstico , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/terapia , Infecções por Papillomavirus/diagnóstico , Neoplasias Faríngeas/diagnóstico , Guias de Prática Clínica como Assunto , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Incidência , Neoplasias Laríngeas/terapia , Neoplasias Laríngeas/virologia , Laringe/virologia , Masculino , Pessoa de Meia-Idade , Boca/virologia , Neoplasias Bucais/virologia , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/virologia , Neoplasias Faríngeas/terapia , Neoplasias Faríngeas/virologia , Faringe/virologia , Polônia/epidemiologia , Prevalência
2.
Acta Otolaryngol ; 132(4): 404-8, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22235981

RESUMO

CONCLUSION: The high prevalence of pathological changes in the contralateral ear (CLE) among children treated because of middle ear cholesteatoma (MEC) was observed. Evolution of many retraction pockets into cholesteatoma points to the need for early intervention in those patients, especially those with concomitant attic retraction pockets and secretory otitis media (SOM). OBJECTIVES: The aim of the study was to assess the frequency of pathological changes in the CLE of children operated because of MEC, and to determine their clinical evolution. METHODS: Retrospective analysis was performed on the basis of medical records of 202 patients treated surgically for MEC in the years 1998-2011. The mean age of included patients was 11 years and the mean observation period was 54 months. Otoscopic findings before surgery were compared with the latest examination. RESULTS: At the time of surgery for MEC, 54.5% of CLEs presented with abnormalities. The most frequent findings were retraction of the tympanic membrane (30%) and SOM, 22.4%. Also, 7% of patients presented with bilateral MEC. Thirty-four percent (20 cases) of retraction pockets diagnosed at the beginning of the observation period required surgical intervention. During the intervention in 20% of cases (12/59 cases) diagnosis of cholesteatoma was confirmed. At the end of the observation period bilateral cholesteatoma was diagnosed in 12.9% of children.


Assuntos
Colesteatoma da Orelha Média/patologia , Otite Média com Derrame/complicações , Membrana Timpânica/patologia , Adolescente , Criança , Pré-Escolar , Colesteatoma da Orelha Média/complicações , Colesteatoma da Orelha Média/cirurgia , Humanos , Estudos Retrospectivos
3.
Otolaryngol Pol ; 57(1): 99-101, 2003.
Artigo em Polonês | MEDLINE | ID: mdl-12741152

RESUMO

We present results of multi center, open clinical trial on using cefprozil (cephalosporin II generation) in acute otitis media in children. Results indicate very good treatments effect (89.3%) and good tolerance of the drug (10.7% side effects).


Assuntos
Cefalosporinas/uso terapêutico , Otite Média/tratamento farmacológico , Doença Aguda , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Resultado do Tratamento , Cefprozil
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA